Biofrontera Inc Warrants (27/10/2026) BFRIW 深 滬
等待開盤 10-28 09:30:00 美东时间
0.14
+0.043
+44.18%
華盛通- 最 高0.14
- 今 開0.14
- 成交量 65股
- 最 低 0.14
- 昨 收 0.0971
- 總市值 0
- 52周最高 0.277
- 市盈率 靜 --
- 換手率 Infinity.00%
- 52周最低 0.0251
- 委 比 89.89%
- 總股本 --
- 歷史最高 9.18
- 量 比 0.01
- 振 幅 0.00%
- 歷史最低 0.005
- 每 手 1
- 風險率 0.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Biofrontera Finalizes U.S. Rights Acquisition Deal
Biofrontera ( ($BFRI) ) has shared an update. On October 20, 2025, Biofrontera ...
10-25 05:48
Biofrontera Completes Restructuring and Asset Purchase
Biofrontera ( ($BFRI) ) has issued an announcement. On October 23, 2025, Biofro...
10-23 21:21
Biofrontera AG Announces Significant Impairment Losses
Biofrontera ( ($DE:B8FK) ) has shared an announcement. Biofrontera AG has annou...
09-25 05:27
Biofrontera Completes Treatment Phase In Phase 3 Trial Of Ameluz For Actinic Keratosis On Body; Supplemental New Drug Application Planned For Submission In Q2 2026
All 172 patients have now entered the 12-month follow-up phaseTrial involves larger surface areas, building on the approval in October 2024 for use of up to 3 tubes of Ameluz® per treatmentStudy results expected to
09-16 22:32
Biofrontera shares are trading higher after the company announced that the final patient in its Phase 2b clinical trial evaluating Ameluz for the treatment of moderate to severe acne vulgaris completed participation. The company expects to receive top-line data in Q1 2026 and will present findings to the FDA in Q3 2026 as the basis for a future Phase III program.
Biofrontera shares are trading higher after the company announced that the fina...
08-25 20:29
Biofrontera Q2 EPS $(0.57) Misses $(0.42) Estimate, Sales $9.03M Beat $8.30M Estimate
Biofrontera (NASDAQ:BFRI) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.42) by 35.71 percent. This is a 1040 percent decrease over losses of $(0.05) per share from the
08-14 05:21
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
A Look at Biofrontera's Upcoming Earnings Report
Biofrontera (NASDAQ:BFRI) is set to give its latest quarterly earnings report o...
08-13 01:02
Biofrontera Finalizes Acquisition of U.S. Ameluz Rights
Biofrontera ( ($BFRI) ) just unveiled an announcement. On June 30, 2025, Biofro...
07-01 21:15
Biofrontera Completes Strategic Restructuring Agreement
An announcement from Biofrontera ( ($DE:B8FK) ) is now available. Biofrontera A...
07-01 07:58
